MYH7 antibody (Middle Region)
Quick Overview for MYH7 antibody (Middle Region) (ABIN2776777)
Target
See all MYH7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Sequence
- TLEDQMNEHR SKAEETQRSV NDLTSQRAKL QTENGELSRQ LDEKEALISQ
-
Predicted Reactivity
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 86%
-
Characteristics
- This is a rabbit polyclonal antibody against Myh7. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide corresponding to a region of Mouse
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 1935 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies." in: Human molecular genetics, Vol. 24, Issue 17, pp. 4916-32, (2016) (PubMed).
: "Role of Cytoskeletal Tension in the Induction of Cardiomyogenic Differentiation in Micropatterned Human Mesenchymal Stem Cell." in: Advanced healthcare materials, Vol. 4, Issue 9, pp. 1399-407, (2015) (PubMed).
: "Investigating the spatial distribution of integrin β₁ in patterned human mesenchymal stem cells using super-resolution imaging." in: ACS applied materials & interfaces, Vol. 6, Issue 18, pp. 15686-96, (2014) (PubMed).
: "
-
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies." in: Human molecular genetics, Vol. 24, Issue 17, pp. 4916-32, (2016) (PubMed).
-
-